The Efficacy and Safety of Qianweitai (Silodosin Capsule) Versus Tamsulosin in the Treatment of BPH
Status:
COMPLETED
Trial end date:
2024-07-09
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to learn if Qianweitai (QWT, silodosin capsule) works to treat BPH/LUTS in male adults. It will also learn the safety about QWT. The main questions it aims to answer are:
1. Whether QWT is non inferior to tamsulosin in the reduction of IPSS total score
2. Dose QWT have other advantages in the improvement of LUTS?
Participants will:
1. Orally take QWT twice daily or tamsulosin once daily for 12 weeks.
2. Visit the clinic at week 1 248 and 12 for checkups and tests.